The most common safety issue that resulted in label changes for vaccines was a restriction on the population to be vaccinated, such as pregnant or immunocompromised patients.
28 Jul 2020
After four weeks, bivalent booster vaccines were 47.5% effective against hospitalization or death from COVID-19, a study in North Carolina found, while a Brazilian trial showed that fluvoxamine plus inhaled budesonide significantly reduced the risk of progression to severe disease among high-risk patients with symptomatic COVID-19.
18 Apr 2023
The CDC is anticipating a resumption of seasonal flu activity in the U.S., but the potential effects of the COVID-19 pandemic this year remain unknown.
1 Oct 2021
The CDC's monitoring system found low rates of anaphylaxis after a first dose of the Pfizer-BioNTech COVID-19 vaccine, peer-reviewed data were published on the Moderna vaccine, and alternate vaccine administration strategies were evaluated.
12 Jan 2021
The FDA and CDC endorsed boosters of the Johnson & Johnson and Moderna vaccines. Recent research showed that COVID-19 vaccination was not associated with miscarriage, and a small financial incentive for receiving a COVID-19 vaccine or providing transportation to a vaccination site increased uptake.
26 Oct 2021
While most physicians surveyed about current Advisory Committee on Immunization Practices (ACIP) recommendations responded that they found them to be very clear or somewhat clear, when tested with questions about the recommendations and several case scenarios, many of the survey respondents answered incorrectly.
1 Apr 2018
ACP offers free patient education resources that explain how vaccines are safe, save lives, and protect the people around us.
26 Nov 2019
Multiple recent studies assessed the effectiveness of the COVID-19 vaccines at different time intervals after vaccination, while others looked at the impact of booster shots. Results of a survey suggested that racial differences in vaccine uptake may be attributable to social barriers.
7 Dec 2021
This issue covers such topics as HPV vaccination, news from ObesityWeek, and a preview of upcoming events at Internal Medicine Meeting 2017.
1 Feb 2017
Thrombosis with thrombocytopenia is a risk with the Johnson & Johnson (Janssen) vaccine, but not those using mRNA technology, one study found, while other research quantified the vaccines' effectiveness over time. A trial found that monoclonal antibodies reduced progression from asymptomatic to symptomatic infection.
18 Jan 2022